Your email has been successfully added to our mailing list.

×
0.00137174211248286 0.00416421712718006 0 0.00333137370174411 -0.000391926317852166 0.0129335684891241 0.0137174211248286 0.0072506368802666
Stock impact report

Esperion's combo therapy lowers cholesterol level by 35 percent, shares surge [Reuters (UK)]

Esperion Therapeutics, Inc. (ESPR) 
Last esperion therapeutics, inc. earnings: 2/27 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.esperion.com
Company Research Source: Reuters
Esperion's combo therapy lowers cholesterol level by 35 percent, shares surge | Reuters Reuters Staff 2 Min Read (Reuters) - Esperion Therapeutics Inc said on Monday a combination of its drug, bempedoic acid, taken along with Merck’s Zetia lowered cholesterol level by 35 percent in a late-stage study, sending the company’s shares up as much as 11 percent. The 12-week study evaluated the efficacy and safety of the bempedoic acid-ezetimibe combination pill compared with bempedoic acid, ezetimibe or placebo in 382 high-risk patients. It showed a 35 percent reduction in low-density lipoprotein cholesterol (LDL-C), or bad cholesterol, for the combination pill compared to a 3 percent for placebo, 24 percent for Zetia or ezetimibe, and 20 percent for bempedoic acid. “This combo pill fills a market need that is there ... results are really compelling,” Chief Executive Officer Tim Mayleben said in a conference call. Esperion said the combo therapy could be the first-ever treatment capable of r Show less Read more
Impact Snapshot
Event Time:
ESPR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
ESPR alerts

from News Quantified
Opt-in for
ESPR alerts

from News Quantified